Growth Metrics

SELLAS Life Sciences Group (SLS) Net Cash Flow: 2010-2024

Historic Net Cash Flow for SELLAS Life Sciences Group (SLS) over the last 15 years, with Dec 2024 value amounting to $11.4 million.

  • SELLAS Life Sciences Group's Net Cash Flow rose 220.80% to $11.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $17.1 million, marking a year-over-year increase of 214.67%. This contributed to the annual value of $11.4 million for FY2024, which is 177.81% up from last year.
  • As of FY2024, SELLAS Life Sciences Group's Net Cash Flow stood at $11.4 million, which was up 177.81% from -$14.6 million recorded in FY2023.
  • In the past 5 years, SELLAS Life Sciences Group's Net Cash Flow registered a high of $28.0 million during FY2020, and its lowest value of -$14.6 million during FY2023.
  • For the 3-year period, SELLAS Life Sciences Group's Net Cash Flow averaged around -$2.5 million, with its median value being -$4.2 million (2022).
  • Per our database at Business Quant, SELLAS Life Sciences Group's Net Cash Flow spiked by 1,355.09% in 2020 and then crashed by 245.04% in 2023.
  • Yearly analysis of 5 years shows SELLAS Life Sciences Group's Net Cash Flow stood at $28.0 million in 2020, then tumbled by 149.77% to -$13.9 million in 2021, then surged by 69.67% to -$4.2 million in 2022, then slumped by 245.04% to -$14.6 million in 2023, then spiked by 177.81% to $11.4 million in 2024.